Strategic advisory · New York
N-tanglement helps neuroscience, neurotech and computational biotech companies build the partnerships, investor stories and strategy that carry early science toward patients.
|ψ⟩ = 1/√2 ( |lab⟩|boardroom⟩ + |boardroom⟩|lab⟩ )
Services
Engagements are scoped to the problem: a single financing narrative, a partnering push ahead of JPM, or an ongoing advisory role.
Partnerships
Find, structure and close the collaborations that matter: academic research alliances, licensing, and biopharma partnerships built around platforms and data.
Narrative
Turn dense data into a story that analysts, investors and partners can act on, from the first deck to the conference stage.
Computation
Help drug developers evaluate new computational approaches, and help platform companies speak the language of pharma R&D.
Who I work with
About
Nell has spent twelve years translating emerging neuroscience into partnerships, regulatory milestones and funding. Most recently Executive Director, Business Development & Corporate Affairs at Anavex Life Sciences, she built research collaborations with academic institutions worldwide, structured licensing and partnership agreements, sourced investigators for preclinical and clinical CNS programs, and led investor relations.
She holds a neuroscience degree from Tulane, has co-authored peer-reviewed research, and has presented at the Society for Neuroscience, the Alzheimer’s Association International Conference, BIO and the J.P. Morgan Healthcare Conference.
Scientific Organizing Committee, New York Academy of Sciences symposium Alzheimer’s Disease Therapeutics: Alternatives to Amyloid
Advisor, TectoniQ Medical
InQuanto quantum computing program, University of Cambridge
Contact
Tell me about your program, your partnering goals or the story you need to tell. I read and answer every note personally.
Or connect with me on LinkedIn.